Table 4.

Combination clinical trials with idelalisib in patients with NHL

Combination clinical trials with idelalisib in patients with NHL
Combination clinical trials with idelalisib in patients with NHL

OR indicates overall response; PFS, progression-free survival; R/R, relapsed/refractory; NHL, non-Hodgkin's lymphoma; CR, complete response; FL, follicular lymphoma; SLL, small lymphocytic lymphoma; and MCL, mantle cell lymphoma.

Close Modal

or Create an Account

Close Modal
Close Modal